| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Sheng,Bao-Xi | Chairman | 35.79% | BORA PHARMACEUTICALS CO., LTD. |
| Chen,Shi-Min | Vice Chairman | 35.79% | BORA PHARMACEUTICALS CO., LTD. |
| Pan,Jia-Yue | Director | 2.69% | Elf International Co., LTD |
| Xu,Xu-Zhi | Director | 2.64% | XIN HUANG INVESTMENT LTD. |
| Zheng,Dun-Qian | Independent Director | 0.00% | |
| Ke,Cui-Ting | Independent Director | 0.00% | |
| Xie,Zhen-Wu | Independent Director | 0.17% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 483,059 | 571,111 | 350,446 |
| Operating cost | 202,799 | 334,202 | 94,931 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 280,260 | 236,909 | 255,515 |
| Unrealized profit (loss) on sales of goods | 73 | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 280,187 | 236,909 | 255,515 |
| Operating expenses | 195,960 | 186,427 | 111,119 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 84,227 | 50,482 | 144,396 |
| Non-operating income and expenses | 372 | 3,794 | -866 |
| Net profit (loss) before tax | 84,599 | 54,276 | 143,530 |
| Income tax expense (benefits) | 13,162 | 9,853 | 7,946 |
| Net profit (loss) of ongoing business for the current period | 71,437 | 44,423 | 135,584 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 71,437 | 44,423 | 135,584 |
| Other comprehensive profit (loss), net | 76 | -678 | 2,546 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 71,513 | 43,745 | 138,130 |
| Net profit (loss) attributable to owners of parent company | 71,438 | 44,075 | 135,203 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | 0 | 311 | - |
| Net profit (loss) attributable to non-controlling interests | -1 | 37 | 381 |
| Comprehensive profit (loss) attributable to owners of parent company | 71,514 | 43,397 | 137,749 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | 0 | 311 | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -1 | 37 | 381 |
| Basic earnings per share (yuan) | 1 | 1 | 4 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 83,081 | 55,984 | 210,826 |
| Net cash inflows (outflows) from investing activities | -60,706 | 218,775 | -34,309 |
| Net cash inflow (outflow) from financing activities | -72,562 | -35,459 | -145,185 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 154 | -678 | 14 |
| Increase (decrease) in cash and cash equivalents in the current period | -50,033 | 238,622 | 31,346 |
| Beginning balance of cash and cash equivalents | 362,192 | 123,570 | 346,441 |
| Ending balance of cash and cash equivalents | 312,159 | 362,192 | 377,787 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 827,867 | 811,679 | 514,455 |
| Non-current asset | 2,855,855 | 2,843,780 | 391,404 |
| Total asset | 3,683,722 | 3,655,459 | 905,859 |
| Current liability | 232,134 | 203,398 | 80,552 |
| Non-current liability | 239,391 | 251,708 | 273,272 |
| Total liability | 471,525 | 455,106 | 353,824 |
| share capital | 593,891 | 593,891 | 335,486 |
| Equity - secruity token | - | - | - |
| capital reserve | 2,534,391 | 2,555,177 | 36,922 |
| retained earning | 81,907 | 49,072 | 186,754 |
| Other equity | -602 | -678 | -10,052 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 3,209,587 | 3,197,462 | 549,110 |
| Equity attributable to former owner of business combination under common control | 0 | 0 | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 2,610 | 2,891 | 2,925 |
| Total Equity | 3,212,197 | 3,200,353 | 552,035 |
| Share capital awaiting retirement (unit: share) | - | - | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 54 | 53 | 16 |
